Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 627

1.

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.

Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun SY, Park CK.

Dig Liver Dis. 2008 Apr;40(4):267-74. Epub 2007 Dec 4.

PMID:
18055281
2.

Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis.

Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, Manesis EK, Archimandritis AJ.

Eur J Gastroenterol Hepatol. 2006 Apr;18(4):389-96.

PMID:
16538110
3.

Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.

Kim BK, Kim SA, Park YN, Cheong JY, Kim HS, Park JY, Cho SW, Han KH, Chon CY, Moon YM, Ahn SH.

Liver Int. 2007 Sep;27(7):969-76.

PMID:
17696936
4.

[Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].

Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.

Korean J Hepatol. 2009 Dec;15(4):454-63. doi: 10.3350/kjhep.2009.15.4.454. Korean.

5.

13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.

Dinesen L, Caspary WF, Chapman RW, Dietrich CF, Sarrazin C, Braden B.

Dig Liver Dis. 2008 Sep;40(9):743-8. doi: 10.1016/j.dld.2008.01.013. Epub 2008 Mar 12.

PMID:
18339592
6.

Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.

Lee KG, Seo YS, An H, Um SH, Jung ES, Keum B, Yim HJ, Jeen YT, Chun HJ, Kim CD, Ryu HS.

J Gastroenterol Hepatol. 2010 Jan;25(1):94-100. doi: 10.1111/j.1440-1746.2009.05953.x. Epub 2009 Sep 27.

PMID:
19793171
7.

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.

Hepatology. 2005 Jun;41(6):1376-82.

PMID:
15915455
8.

Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.

Carvalho-Filho RJ, Schiavon LL, Narciso-Schiavon JL, Sampaio JP, Lanzoni VP, Ferraz ML, Silva AE.

Liver Int. 2008 Apr;28(4):486-93. doi: 10.1111/j.1478-3231.2008.01675.x.

PMID:
18339075
9.

Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?

Vardar R, Vardar E, Demiri S, Sayhan SE, Bayol U, Yildiz C, Postaci H.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1459-65.

PMID:
19950810
10.

Non-invasive models for predicting histology in patients with chronic hepatitis B.

Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG.

Liver Int. 2006 Aug;26(6):666-72.

PMID:
16842322
12.

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.

Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.

J Gastroenterol Hepatol. 2007 Nov;22(11):1904-8.

PMID:
17914968
13.

Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.

Lesmana CR, Salim S, Hasan I, Sulaiman AS, Gani RA, Pakasi LS, Lesmana LA, Krisnuhoni E, Budihusodo U.

J Clin Pathol. 2011 Oct;64(10):916-20. doi: 10.1136/jclinpath-2011-200044. Epub 2011 Jun 13.

PMID:
21670074
14.

APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.

Pissaia A Jr, Borderie D, Bernard D, Scatton O, Calmus Y, Conti F.

Transplant Proc. 2009 Mar;41(2):679-81. doi: 10.1016/j.transproceed.2008.12.014.

PMID:
19328955
15.

APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C.

Snyder N, Gajula L, Xiao SY, Grady J, Luxon B, Lau DT, Soloway R, Petersen J.

J Clin Gastroenterol. 2006 Jul;40(6):535-42.

PMID:
16825937
16.

[A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].

Tu XL, Xiao YQ, Chen F.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jan;17(1):28-32. Chinese.

PMID:
19203448
17.

A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice.

Giannini EG, Zaman A, Ceppa P, Mastracci L, Risso D, Testa R.

J Clin Gastroenterol. 2006 Jul;40(6):521-7.

PMID:
16825935
18.
19.

Aspartate aminotransferase-to-platelet ratio index for fibrosis and cirrhosis prediction in chronic hepatitis C patients.

Silva Jr RG, Fakhouri R, Nascimento TV, Santos IM, Barbosa LM.

Braz J Infect Dis. 2008 Feb;12(1):15-9.

20.

Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?

Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR; VA HCV-001 Study Group..

J Clin Gastroenterol. 2008 Aug;42(7):827-34. doi: 10.1097/MCG.0b013e318046ea9a.

PMID:
18285716

Supplemental Content

Support Center